Related Experiment Video
Updated: Feb 23, 2026
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Complement genomics and antibody-mediated rejection in heart recipients
1Clinical Immunology Department, Hospital General Universitario Gregorio Marañón, the Immunology Unit, Complutense University, and Instituto para la Investigación Biomédica del Hospital Gregorio Marañón, Madrid, Spain.
Insights
Genetic variations in complement pathways may predict antibody-mediated rejection (AMR) after heart transplantation. Specific single-nucleotide polymorphisms in MBL2 and CFP genes are linked to AMR development in heart recipients.
Area of Science:
- Immunogenetics
- Transplantation Immunology
Background:
- Antibody-mediated rejection (AMR) is a significant complication following heart transplantation.
- The complement system plays a crucial role in the pathogenesis of AMR.
Discussion:
- This study investigated the association between genetic variations in complement pathway genes and AMR in heart transplant recipients.
- Next-generation sequencing was employed to analyze 51 complement-related genes in 46 patients.
Key Insights:
- Two single-nucleotide polymorphisms (SNPs) showed a significant association with AMR: p.Gly54Asp-MBL2 in the mannose-binding lectin 2 (MBL2) gene and p.Asn428(p=)-CFP in the properdin (CFP) gene.
- These findings suggest that specific genetic variations in complement genes may influence the risk of developing AMR.
Outlook:
- Further research with larger cohorts is warranted to validate these findings.
- Complement gene polymorphisms could potentially serve as biomarkers for predicting AMR risk in heart transplant candidates.
- Targeting complement pathways may offer novel therapeutic strategies to prevent AMR.
Abstract:
In this issue of the Journal of Heart and Lung Transplantation, Marrón-Liñares et al report the results of an interesting study in which they evaluated 51 genes associated with the complement pathway in a small number of heart recipients to explore their relationship with antibody-mediated rejection (AMR). Next-generation sequencing was used in 46 heart transplant recipients (23 with AMR and 23 without AMR). The authors identified a significant association of 2 single-nucleotide polymorphisms with the absence or presence of AMR, respectively, p.Gly54Asp-MBL2 in the mannose-binding lectin (MBL) 2 gene and p.Asn428(p=)-CFP in the alternative complement factor properdin (CFP) gene. This article is a new contribution to the heart transplant literature. It suggests that complement single-nucleotide polymorphisms may influence circulating levels of selected proteins of both the lectin pathway and alternative complement pathways, thus potentially determining which patients will develop AMR.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
00:42Cross-reactivity